Background Black patients with breast cancer may be at greater risk for chemotherapy-
related hematologic toxicity than white patients because of lower baseline blood cell counts …

Purpose Breast cancer outcomes are worse among black women and women of lower
socioeconomic status. The purpose of this study was to investigate racial and social …

Purpose We conducted a systematic review and meta-analysis to measure the extent to
which race is associated with delayed initiation or receipt of inadequate chemotherapy …

Recent breast cancer treatment studies conducted in large urban settings have reported
racial disparities in the appropriate use of adjuvant chemotherapy. This article presents the …

The use of chemotherapy in the treatment of selected types of early breast cancer has been
endorsed as a measure of high-quality care by numerous professional organizations and …

Purpose Underuse of adjuvant therapy is a potentially important and remediable
explanation for the inferior survival of minority women with breast cancer. We sought to …

Objective. To examine racial disparities associated with breast cancer treatment and survival
in elderly patients with early stage operable breast cancer. Methods. We studied 23,110 …

Introduction Black women appear to have worse outcome after diagnosis and treatment of
breast cancer. It is still unclear if this is because Black race is more often associated with …

BACKGROUND: Racial disparities in breast cancer outcomes are attributed to differences in
baseline tumour characteristics and biology, stage, age, ethnic background and …

Purpose. The purpose of this study was to investigate the impact of race and obesity on dose
and dose intensity of adjuvant chemotherapy. Methods. We abstracted data on patient/tumor …